INS and type 1 diabetes mellitus: Independence from exogenous insulin, lower insulin dose requirement, decreased HbA1clevels, and improvement of C-peptide levels were reported after autologous HSCstherapy in patients with T1D (96,97,99,100,101,102).Immunoablative conditioning may account for some of these benefits.